ebanga 400 MG Injection

RxCUI
2472161
RxNorm name
ebanga 400 MG Injection
Display name
ebanga 400 MG Injection
Full name
ebanga 400 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761172Ebangaansuvimab-zykl351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EbangaANSUVIMABEmergent BioDefense Operations Lansing LLCde220c8f-ffcb-4522-a6a2-c7d6ce5de1b52026-08-13Warnings, Adverse reactionsExact identifier
rxcui: 2472161

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9c008384-379d-48d3-b5a5-9809ed0f655cebanga 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [Ebanga] [SBD] · Ebanga 400 MG Injection [SY]35These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 202020250210
de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5ebanga 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [Ebanga] [SBD] · Ebanga 400 MG Injection [SY]32These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA TM (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 202020260220